Author: Specialty Hospital Staff

24 Oct Study Takes a Look at Contemporary Use of Hybrid Revascularization

Yesterday researchers noted that Hybrid revascularization, combining percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG), for the treatment of multivessel coronary artery disease, is used infrequently. According to findings published in the American Heart Journal, a new analysis, reveals that while the risk-adjusted...

Read More

26 Sep Greater Treatment Options for AVS Patients with a Lower Surgical Risk of Major Complications

Last month, the U.S. Food and Drug Administration (FDA), an agency within the U.S. Department of Health and Human Services, that protects the public health, approved an expanded indication for several transcatheter heart valves to include patients with severe aortic valve stenosis (Sapien 3, Sapien 3 Ultra, CoreValve...

Read More